Lobenzarit disodium inhibits the constitutive NO-cGMP metabolic pathways. Possible involvement as an immunomodulatory drug

• Päätekijät: J. Padrón (Tekijä), A. Rojas (Tekijä), L. Glaría (Tekijä), L. Caveda (Tekijä), R. Delgado (Tekijä), M. Torres (Tekijä), O. Martínez (Tekijä), E. López (Tekijä), A. Beltrán (Tekijä), M. Palacios (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Hindawi Limited, 1995-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Lobenzarit disodtulIl (CCA) is a novel immunomodulatory drug useful in the treatment of chronic inflammations. Its principal mechanism of action seems to be through enhancing the T suppressor/T helper lymphocyte ratio. However, the molecular basis for these actions remains unclear. In this study it...